Trial Profile
A randomized double blind, placebo controlled balanced 4-way crossover study to assess the efficacy of single oral doses of PF-00592379 on erectile function, using 100mg sildenafil as a positive control
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Aug 2019
Price :
$35
*
At a glance
- Drugs PF 592379 (Primary) ; Sildenafil
- Indications Erectile dysfunction
- Focus Therapeutic Use
- Sponsors Pfizer
- 20 Nov 2006 New trial record.